Helius Medical Technologies (NASDAQ: HSDT) is one of 59 public companies in the “Electromedical equipment” industry, but how does it contrast to its peers? We will compare Helius Medical Technologies to similar businesses based on the strength of its risk, dividends, institutional ownership, earnings, valuation, profitability and analyst recommendations.
This is a breakdown of recent ratings and target prices for Helius Medical Technologies and its peers, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Helius Medical Technologies||0||0||0||0||N/A|
|Helius Medical Technologies Competitors||339||1008||1699||86||2.49|
Institutional & Insider Ownership
8.0% of Helius Medical Technologies shares are held by institutional investors. Comparatively, 45.2% of shares of all “Electromedical equipment” companies are held by institutional investors. 17.4% of Helius Medical Technologies shares are held by company insiders. Comparatively, 16.4% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
This table compares Helius Medical Technologies and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Helius Medical Technologies||-2,965.26%||-289.95%||-188.52%|
|Helius Medical Technologies Competitors||-310.31%||-90.21%||-20.70%|
Volatility & Risk
Helius Medical Technologies has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, Helius Medical Technologies’ peers have a beta of 24.48, indicating that their average share price is 2,348% more volatile than the S&P 500.
Valuation and Earnings
This table compares Helius Medical Technologies and its peers gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Helius Medical Technologies||$1.50 million||-$9.78 million||-1.19|
|Helius Medical Technologies Competitors||$1.01 billion||$119.86 million||23.14|
Helius Medical Technologies’ peers have higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Helius Medical Technologies peers beat Helius Medical Technologies on 9 of the 10 factors compared.
Helius Medical Technologies Company Profile
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.